Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma
By Hedy L. Kindler, MD Posted: August 2018 The American Society of Clinical Oncology (ASCO) has issued its first-ever clinical practice guidelines on the management of patients with malignant pleural […] Read more
By Rachel Rosenthal, PhD, MSc, andCharles Swanton, FRCP, BSc, PhD Posted: June 2018 An evolving tumor and the immune system continuously adapt to each other. As a tumor develops increasing […] Read more
By Gregory J. Riely, MD Posted: June 2018 The changes seen in the 2018 update of the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for […] Read more
Highlights of the 8th Edition of the TNM Staging System: Practicalities and Tools
Hisao Asamura+more
Editor’s Note: The following was written on behalf of the IASLC Staging and Prognostic Factors Committee. The IASLC Staging and Prognostic Factors Committee (SPFC) proposed revisions to the lung cancer […] Read more
By Vassiliki Papadimitrakopoulou, MD Posted: June 2018 The Lung Master Protocol Trial (Lung-MAP) was designed in 2014 as a phase II/III trial overseen by a private–public collaboration among institutions participating […] Read more
By Anna Farago, MD, PhD Posted: June 2018 Small cell lung cancer (SCLC) accounts for approximately 15% of all new lung cancer diagnoses in the United States. Approximately 30% of […] Read more
Oncologic Biologic Biosimilars Are Coming to Market: Are You Ready?
Biosimilars have proven themselves to the U.S. FDA, but clinicians are still wary. By Leah K. Lawrence Posted: June 2018 Healthcare providers are more than familiar with the use of […] Read more
By Tiziana Vavalà, MD, andSilvia Novello, MD, PhD Posted: April 2018 Approximately 1.8 million new lung cancer cases worldwide are diagnosed annually, and 85% of these cases are NSCLC. Only […] Read more
By Annemie Snoeckx, MD, andPaul E. Van Schil, MD, PhD Posted: April 2018 No universally accepted guidelines or management protocols exist for diagnosis and treatment of screen-detected nodules. Radiologic management […] Read more
Availability of next-generation sequencing continues to improve, but current technology cannot speed turnaround time of results. Posted: February 2018 The standard of care for all patients diagnosed with advanced nonsquamous […] Read more